- Clinical Trials
- July 2024
- 777 Pages
Global
From €3088EUR$3,450USD£2,631GBP
- Report
- May 2025
- 131 Pages
Global
From €3908EUR$4,365USD£3,328GBP
€4342EUR$4,850USD£3,698GBP
- Report
- May 2025
- 138 Pages
Global
From €3908EUR$4,365USD£3,328GBP
€4342EUR$4,850USD£3,698GBP
- Report
- September 2023
- 100 Pages
Global
From €5326EUR$5,950USD£4,537GBP
- Report
- January 2023
- 470 Pages
Global
From €4476EUR$5,000USD£3,813GBP
- Report
- February 2024
- 120 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- March 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,164GBP
- Report
- January 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,164GBP
- Report
- January 2024
- 200 Pages
Global
From €3715EUR$4,150USD£3,164GBP
- Report
- August 2023
- 145 Pages
Global
From €2820EUR$3,150USD£2,402GBP
- Report
- January 2022
- 60 Pages
Global
From €3536EUR$3,950USD£3,012GBP
- Report
- January 2022
- 60 Pages
Global
From €3536EUR$3,950USD£3,012GBP
- Report
- January 2022
- 60 Pages
Global
From €3536EUR$3,950USD£3,012GBP
- Report
- March 2024
- 303 Pages
Global
From €7117EUR$7,950USD£6,062GBP
- Report
- May 2024
- 168 Pages
Global
From €2238EUR$2,500USD£1,906GBP
From €2663EUR$2,975USD£2,268GBP
€3133EUR$3,500USD£2,669GBP
- Report
- September 2024
- 88 Pages
Japan
From €2663EUR$2,975USD£2,268GBP
€3133EUR$3,500USD£2,669GBP
- Report
- February 2024
- 185 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- June 2024
- 200 Pages
Global
From €7117EUR$7,950USD£6,062GBP
- Report
- June 2024
- 200 Pages
Global
From €7117EUR$7,950USD£6,062GBP

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators.
Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more